🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 56565P103
- IPO
- 10/24/2025 · $17.00/share
Business: MapLight Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. MapLight’s lead product candidate, ML-007C-MA, is an oral, extended-release, fixed-dose combination of an investigational M1/M4 muscarinic agonist, ML-007, co-formulated with a peripherally acting anticholinergic.
Company Contact
- CEO
- Christopher A. Kroeger
- CFO
- Vishwas Setia
- Headquarters
- 800 Chesapeake Drive, Redwood City, CA 94063
- Phone
- 650-839-4360
- Investor Relations
- investors@maplightrx.com